Biogen and Eisai launch multiple initiatives to help patients with Alzheimer’s disease access ADUHELM™

by NASDAQ Market News June 7, 2021

NASDAQ Market News
Click here to email author

The Top Issues Concerning Pregnant Women and Women Trying to Conceive About the COVID-19 Vaccine

FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease

Ads